International Clinical Trial: LncRNA regulates the methylation of the Beclin1 promoter region to promote autophagy to induce triphenoxamine resistance in breast cancer

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114871) titled 'LncRNA regulates the methylation of the Beclin1 promoter region to promote autophagy to induce triphenoxamine resistance in breast cancer' on Dec. 18, 2025.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University

Condition: How can breast cancer mediate triphenoxylamine resistance through autophagy?

Intervention: Experimental group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Experimental group:100;Control group:100;

Countries of Recruitment: China

To know ...